Integra LifeSciences to Spotlight Neurosurgical Product Portfolio at the Congress of Neurological Surgeons (CNS) Annual MeetingGlobeNewsWire • 10/08/25
Integra LifeSciences Strengthens Leadership with Appointment of New Chief Medical OfficerGlobeNewsWire • 09/22/25
Integra LifeSciences Holdings Corporation (IART) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeeking Alpha • 09/10/25
Integra LifeSciences Leadership to Present at Wells Fargo and Morgan Stanley Healthcare Investor ConferencesGlobeNewsWire • 08/29/25
Integra LifeSciences Holdings Corporation (IART) Q2 2025 Earnings Call TranscriptSeeking Alpha • 08/01/25
Compared to Estimates, Integra (IART) Q2 Earnings: A Look at Key MetricsZacks Investment Research • 07/31/25
Integra LifeSciences (IART) Beats Q2 Earnings and Revenue EstimatesZacks Investment Research • 07/31/25
Integra LifeSciences to Host Second Quarter 2025 Financial Results Conference Call on July 31, 2025GlobeNewsWire • 07/14/25
IART Stock May Rise on First Enrollment in AERA Pediatric RegistryZacks Investment Research • 07/03/25
Integra LifeSciences Announces First Patient Enrolled in Acclarent AERA® Pediatric RegistryGlobeNewsWire • 07/02/25
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holdings Corporation - IARTPRNewsWire • 06/22/25
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holdings Corporation - IARTGlobeNewsWire • 06/18/25
INVESTOR NOTICE: Kaskela Law LLC Announces Investigation of Integra LifeSciences Holdings Corp. and Encourages Long-Term Investors to Contact the Firm – IARTAccesswire • 06/09/25
Integra (IART) Up 2.3% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 06/04/25
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Integra LifeSciences Holdings Corporation (IART) And Encourages Shareholders to Reach OutAccesswire • 05/30/25
Is the Options Market Predicting a Spike in Integra LifeSciences Stock?Zacks Investment Research • 05/30/25
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Integra LifeSciences Holdings Corporation (IART) and Encourages Shareholders to Learn More About the InvestigationAccesswire • 05/29/25
Integra LifeSciences Holdings Corporation (IART) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the InvestigationAccesswire • 05/28/25
Bronstein, Gewirtz & Grossman, LLC Encourages Integra LifeSciences Holdings Corporation (IART) Shareholders to Inquire about Securities InvestigationAccesswire • 05/27/25
Integra LifeSciences Holdings Corporation (IART) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the InvestigationAccesswire • 05/26/25
Bronstein, Gewirtz & Grossman, LLC Is Investigating Integra LifeSciences Holdings Corporation (IART) And Encourages Investors to ConnectAccesswire • 05/25/25
Bronstein, Gewirtz & Grossman, LLC Encourages Integra LifeSciences Holdings Corporation (IART) Stockholders to Inquire about Securities InvestigationAccesswire • 05/23/25